Key facts
- This page summarizes Paul J. Sekhri's Form 4 filing for vTv Therapeutics Inc. (VTVT).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 07 Mar 2025, 16:20.
Paul J. Sekhri - 01 Mar 2025 Form 4 Insider Report for vTv Therapeutics Inc. (VTVT)
- Reporting relationship
- Pres, CEO and Exec Chairperson, Director
- Issuer ticker
- VTVT
- Reported as of
- 01 Mar 2025
- Net transaction value
- +$2,123,280
- SEC form
- 4
- Accepted by SEC
- 07 Mar 2025, 16:20:26 UTC
- Prior SEC filing
- 02 Dec 2024
- Next SEC filing
- 02 Jun 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Paul J. Sekhri
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Paul J. Sekhri filed Form 4 for vTv Therapeutics Inc. (VTVT) on 07 Mar 2025.
Change
- Previous filing in this sequence was filed on 02 Dec 2024.
- Current net transaction value: +$2,123,280.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
VTVT
transaction
Derivative
Employee stock option (right to buy)
Award
- Transaction value
- $2,123,280
- Shares
- +108,000
- Change %
- +75%
- Price
- $19.66
- Shares after
- 252,212
- Date
- 01 Mar 2025
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 108,000
- Exercise price
- $19.66
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The options vest 25% on the first anniversary of the grant date and in quarterly equal installments thereafter.